Clinical symptoms and the odds of human T-cell lymphotropic virus type 1–associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: Application of best-fit logistic regression equation based on host genotype, age, and provirus load

References

• Bangham C R. The immune response to HTLV-I. Curr Opin Immunol 2000; 12: 397–402, [INFOTRIEVE], [CSA]
   Google Scholar
• Bunce M, O'Neill C M, Barnardo M C, Krausa P, Browning M J, Morris P J, Welsh K I. Phototyping comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355–367, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen P K, Monteiro J, Usuku K, Yashiki S, Sonoda S, Osame M, Hall W W. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol 1998; 161: 6674–6680, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000; 182: 1343–1349, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Higuchi I, Montemayor E S, Izumo S, Inose M, Osame M. Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers. Muscle Nerve 1993; 16: 472–476, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hisada M, Okayama A, Shioiri S, Spiegelman D L, Stuver S O, Mueller N E. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998; 92: 3557–3561, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Jeffery K J, Siddiqui A A, Bunce M, Lloyd A L, Vine A M, Witkover A D, Izumo S, Usuku K, Welsh K I, Osame M, Bangham C R. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165: 7278–7284, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Usuku K, Hall S E, Matsumoto W, Taylor G P, Procter J, Bunce M, Ogg G S, Welsh K I, Weber J N, Lloyd A L, Nowak M A, Nagai M, Kodama D, Izumo S, Osame M, Bangham C R. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999; 96: 3848–3853, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsuyama W, Kawabata M, Mizoguchi A, Iwami F, Wakimoto J, Osame M. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis—HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity. Clin Exp Immunol 2003; 133: 397–403, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K. HTLV-I and uveitis. Lancet 1992; 339: 1110, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 1998; 4: 586–593, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J NeuroVirol 1996; 2: 345–355, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakao K, Ohba N. Clinical features of HTLV-I associated uveitis. Br J Ophthalmol 1993; 77: 274–279, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1: 441, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225–235, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77: 7415–7419, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sabouri A H, Saito M, Lloyd A L, Vine A M, Witkover A W, Furukawa Y, Izumo S, Arimura K, Marshall S E, Usuku K, Bangham C R, Osame M. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2004; 190: 1279–1285, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Sacher R A, Luban N L, Ameti D I, Friend S, Schreiber G B, Murphy E L. Low prevalence of flower cells in U.S.A. blood donors infected with human T-lymphotrophic virus types I and II. Br J Haematol 1999; 105: 758–763, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Saito M, Higuchi I, Saito A, Izumo S, Usuku K, Bangham C R, Osame M. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 2002; 186: 1231–1241, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 2: 1220, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tachibana N, Okayama A, Ishihara S, Shioiri S, Murai K, Tsuda K, Goya N, Matsuo Y, Essex M, Stuver S, et al. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer 1992; 51: 593–559, [INFOTRIEVE], [CSA]
   Google Scholar
• Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15: 15–37, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vine A M, Witkover A D, Lloyd A L, Jeffery K J, Siddiqui A, Marshall S E, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham C R. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2002; 186: 932–939, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 1982; 79: 2031–2035, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26: 331–335, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar